s6y
Company name or ticker
Search
DEYOUNG JOHN A.
3
Allogene Therapeutics, Inc.: Initial statement of beneficial ownership of securities
Filed
Wednesday, October 10, 2018
Period
Oct 10, 2018
Accession number
0001209191-18-054738
Documents
FORM 3 SUBMISSION
3
POA DOCUMENT
EX-24.3_813290
On sec.gov
Filing index
All files
Complete submission text
SGML header